(Sharecast News) - Analysts at Berenberg slightly lowered their target price on consumer health business Haleon from 517p to 510p on Thursday, stating that 2026 should represent "a turning point" in the group's evolution into a consumer-centric business.

Berenberg believes this will unlock a reacceleration of like-for-like earnings growth to...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE